| RAPT THERAPEUTICS |
| USA |
| Gesundheit |
| US75382E2081 / A418SN |
| 0RA0 (Frankfurt) / RAPT (NASDAQ) |
| FRA:0RA0, ETR:0RA0, 0RA0:GR, NASDAQ:RAPT |
| - |
| https://rapt.com/ |
|
RAPT Therapeutics, Inc. operates as a clinical-sta..
>Volltext.. |
| 416.37 Mio. EUR |
| 275.27 Mio. EUR |
| - |
| -94.12 Mio. EUR |
| -91.38 Mio. EUR |
| -12.19 EUR |
| 2.72 Mio. EUR |
| 35.94 Mio. EUR |
| -78.73 Mio. EUR |
| 12.95 |
| - |
| 19.6% |
| - |
| - |
| - |
| - |
| RAPT THERAPEUTICS, RAPT THERAPEUTIC |
| 20.10.25 |
|